MARCHESE, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 3.654
Totale 3.654
Nazione #
IT - Italia 3.654
Totale 3.654
Città #
Genova 2.702
Genoa 492
Rapallo 445
Bordighera 14
Vado Ligure 1
Totale 3.654
Nome #
Muscle relaxation is impaired in dystonia: a reaction time study 147
A multimodal training modulates short-afferent inhibition and improves complex walking in a cohort of faller older adults with an increased prevalence of Parkinson's disease 140
Posturographic analysis in patients with essential tremor 133
Impairment of transcallosal inhibition in patients with corticobasal degeneration 131
Action Observation and Motor Imagery: Innovative Cognitive Tools in the Rehabilitation of Parkinson's Disease 126
Suicidal ideation in a European Huntington's disease population 125
Discrepancies in reporting the CAG repeat lengths for Huntington's disease 125
Recurring hyperammonemic encephalopathy induced by bacteria usually not producing urease. 124
Intracortical inhibition after paired transcranial magnetic stimulation depends on the current flow direction 117
PRIMARY CERVICAL DYSTONIA AND SCOLIOSIS: A MULTICENTER CASE-STUDY 113
Rehabilitation for Parkinson's disease: Current outlook and future challenges 110
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. 109
Posturographic analysis in patients with essential tremor 108
Spinocerebellar ataxia 17: full phenotype in a 41 CAG/CAA repeats carrier. 106
Different movement disorders responsive to carbamazepine in patients with brainstem focal lesions 105
Postural Stabilization Strategies to Motor Contagion Induced by Action Observation Are Impaired in Parkinson’s Disease 103
Novel parkin mutations detected in patients with early-onset Parkinson's disease. 102
Catatonic features in major depression relieved by electroconvulsive treatment: parallel evaluation of the status of platelet serotonin transporter 98
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. 98
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 97
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. 95
Mitochondrial DNA haplogroup K is associated with lower risk of Parkinson's disease in Italians. 85
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 83
Freezing of gait and Theory of Mind in Parkinson disease 82
Theory of Mind Is Impaired in Mild to Moderate Huntington's Disease Independently from Global Cognitive Functioning 82
Can we improve balance in Parkinson's disease? Yes, 'Wii' can 79
β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease 76
Transcallosal inhibition: A useful tool in the differential diagnosis of parkinsonian syndromes? 73
Quality of sleep in focal dystonia: a case-control study 69
SGCE-negative familiar myoclonus-dystonia syndrome associated with antiphospholipid syndrome 67
Investigating the effects of transcranial direct current stimulation on obstacle negotiation performance in Parkinson disease with freezing of gait: A pilot study 65
Sequential motor learning in parkinsonian patients with freezing of gait 61
Arginine GH stimulation test in bradykinetic-rigid parkinsonisms 52
Is a group-rehabilitation therapy based on action observation effective on reducing freezing of gait in patients with Parkinson’s disease? 48
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor 47
Haptic perception of verticality correlates with postural and balance deficits in patients with Parkinson's disease 44
A gait-based paradigm to investigate central body representation in cervical dystonia patients 40
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? 32
Neuroimaging in idiopathic adult-onset focal dystonia 29
Functional Correlates of Action Observation of Gait in Patients with Parkinson's Disease 28
Artificial intelligence of imaging and clinical neurological data for predictive, preventive and personalized (P3) medicine for Parkinson Disease: The NeuroArtP3 protocol for a multi-center research study 27
Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy 26
A video of best practice recommendations for making botulinum toxin therapy safe during the COVID-19 pandemic 20
Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy 15
Functional Correlates of Action Observation of Gait in Patients with Parkinson's Disease 14
Motor Resonance Flexibility to Emotion-Enriched Context in Parkinson’s Disease Patients 13
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era 13
Baropodometric analysis of stance in stroke patients treated with botulinum toxin for spastic equinovarus foot 10
Neural oscillations modulation during working memory in pre-manifest and early Huntington’s disease 8
Responses to transcran1al magnetic stimulation (TMS) in the masseter muscles of patients with amyotrophic lateral sclerosis (ALS) 6
Brain Networks Modulation during Simple and Complex Gait: A “Mobile Brain/Body Imaging” Study 6
Transcallosal inhibition in patients with corticobasal degeneration 5
Totale 3.717
Categoria #
all - tutte 11.518
article - articoli 11.114
book - libri 0
conference - conferenze 404
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020976 43 27 40 57 92 104 144 76 96 172 91 34
2020/2021286 18 27 25 24 20 19 40 20 25 31 20 17
2021/2022479 23 31 35 61 20 30 39 102 19 41 23 55
2022/2023539 44 52 3 51 90 86 11 38 83 2 70 9
2023/2024410 14 41 17 61 23 69 35 11 15 46 21 57
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 3.717